Susan Johnson
Concepts (388)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Feeding Behavior | 56 | 2025 | 654 | 8.980 |
Why?
| | Food Preferences | 22 | 2024 | 119 | 5.790 |
Why?
| | Infant Nutritional Physiological Phenomena | 12 | 2025 | 146 | 4.550 |
Why?
| | Vegetables | 15 | 2022 | 157 | 4.530 |
Why?
| | Diet | 29 | 2025 | 1278 | 4.070 |
Why?
| | Health Promotion | 18 | 2025 | 741 | 3.400 |
Why?
| | Poverty | 26 | 2025 | 521 | 3.040 |
Why?
| | Meals | 14 | 2023 | 125 | 2.880 |
Why?
| | Child, Preschool | 85 | 2025 | 11074 | 2.720 |
Why?
| | Mothers | 19 | 2023 | 754 | 2.600 |
Why?
| | Energy Intake | 27 | 2025 | 485 | 2.560 |
Why?
| | Infant Food | 5 | 2024 | 65 | 2.460 |
Why?
| | Child Nutritional Physiological Phenomena | 16 | 2021 | 108 | 2.370 |
Why?
| | Caregivers | 9 | 2025 | 877 | 2.340 |
Why?
| | Taste | 9 | 2021 | 229 | 2.290 |
Why?
| | Nutritional Sciences | 7 | 2020 | 44 | 2.200 |
Why?
| | Health Education | 8 | 2021 | 341 | 2.010 |
Why?
| | Parent-Child Relations | 10 | 2021 | 272 | 1.940 |
Why?
| | Parents | 20 | 2025 | 1347 | 1.890 |
Why?
| | Obesity | 30 | 2022 | 2992 | 1.830 |
Why?
| | Food | 9 | 2023 | 164 | 1.760 |
Why?
| | Parenting | 14 | 2021 | 310 | 1.680 |
Why?
| | Child Development | 13 | 2020 | 475 | 1.660 |
Why?
| | Child Behavior | 11 | 2020 | 248 | 1.640 |
Why?
| | Eating | 18 | 2021 | 380 | 1.510 |
Why?
| | Pediatric Obesity | 11 | 2023 | 601 | 1.460 |
Why?
| | Health Knowledge, Attitudes, Practice | 7 | 2022 | 1329 | 1.420 |
Why?
| | Fruit | 8 | 2021 | 140 | 1.370 |
Why?
| | Nutritional Status | 5 | 2022 | 350 | 1.330 |
Why?
| | Food Services | 7 | 2020 | 21 | 1.310 |
Why?
| | Infant | 28 | 2025 | 9465 | 1.240 |
Why?
| | Child Care | 4 | 2023 | 32 | 1.210 |
Why?
| | Humans | 146 | 2025 | 137585 | 1.190 |
Why?
| | Breast Feeding | 7 | 2022 | 440 | 1.180 |
Why?
| | Rural Population | 8 | 2025 | 563 | 1.140 |
Why?
| | Mobile Applications | 4 | 2025 | 183 | 1.120 |
Why?
| | Exercise | 9 | 2025 | 2057 | 1.080 |
Why?
| | Mexican Americans | 6 | 2018 | 120 | 1.040 |
Why?
| | Health Behavior | 8 | 2023 | 762 | 1.000 |
Why?
| | Body Weight | 10 | 2020 | 985 | 0.980 |
Why?
| | Female | 90 | 2025 | 73304 | 0.940 |
Why?
| | Meat | 2 | 2024 | 94 | 0.930 |
Why?
| | Portion Size | 3 | 2017 | 6 | 0.930 |
Why?
| | Family Characteristics | 2 | 2025 | 191 | 0.880 |
Why?
| | Developmental Disabilities | 2 | 2025 | 263 | 0.870 |
Why?
| | Surveys and Questionnaires | 19 | 2023 | 5778 | 0.860 |
Why?
| | Brassica | 2 | 2023 | 5 | 0.850 |
Why?
| | Male | 81 | 2025 | 67762 | 0.840 |
Why?
| | Food Supply | 2 | 2021 | 83 | 0.820 |
Why?
| | Dietary Supplements | 4 | 2022 | 561 | 0.810 |
Why?
| | Body Mass Index | 21 | 2023 | 2389 | 0.800 |
Why?
| | Food Labeling | 2 | 2021 | 14 | 0.800 |
Why?
| | Nutrition Policy | 3 | 2021 | 61 | 0.800 |
Why?
| | Decision Making | 2 | 2024 | 900 | 0.790 |
Why?
| | Self Care | 2 | 2023 | 380 | 0.750 |
Why?
| | Iron | 1 | 2024 | 313 | 0.740 |
Why?
| | Nutritional Requirements | 7 | 2019 | 78 | 0.740 |
Why?
| | Schools | 9 | 2021 | 461 | 0.740 |
Why?
| | Language Development | 1 | 2022 | 61 | 0.730 |
Why?
| | Qualitative Research | 5 | 2025 | 1386 | 0.730 |
Why?
| | Cross-Sectional Studies | 22 | 2025 | 5472 | 0.710 |
Why?
| | Zinc | 1 | 2024 | 297 | 0.700 |
Why?
| | Maternal Behavior | 5 | 2018 | 78 | 0.700 |
Why?
| | Adult | 52 | 2025 | 37929 | 0.700 |
Why?
| | Child | 47 | 2025 | 21935 | 0.700 |
Why?
| | Hunger | 7 | 2021 | 45 | 0.690 |
Why?
| | Students | 4 | 2021 | 622 | 0.680 |
Why?
| | Overweight | 5 | 2015 | 558 | 0.650 |
Why?
| | Writing | 1 | 2021 | 95 | 0.650 |
Why?
| | Nutritive Value | 7 | 2024 | 37 | 0.630 |
Why?
| | School Teachers | 2 | 2019 | 23 | 0.630 |
Why?
| | Exploratory Behavior | 1 | 2020 | 92 | 0.630 |
Why?
| | Climate Change | 1 | 2021 | 183 | 0.610 |
Why?
| | Feeding and Eating Disorders of Childhood | 1 | 2018 | 7 | 0.590 |
Why?
| | Nutrition Surveys | 2 | 2020 | 266 | 0.580 |
Why?
| | Phobic Disorders | 1 | 2018 | 33 | 0.570 |
Why?
| | School Health Services | 2 | 2020 | 238 | 0.570 |
Why?
| | Food Handling | 1 | 2018 | 61 | 0.570 |
Why?
| | Checklist | 1 | 2019 | 93 | 0.570 |
Why?
| | Self-Assessment | 1 | 2018 | 72 | 0.560 |
Why?
| | Child Day Care Centers | 4 | 2013 | 36 | 0.560 |
Why?
| | Television | 5 | 2019 | 75 | 0.540 |
Why?
| | Family Relations | 2 | 2016 | 91 | 0.540 |
Why?
| | Mother-Child Relations | 8 | 2019 | 137 | 0.510 |
Why?
| | Colorado | 15 | 2021 | 4565 | 0.490 |
Why?
| | Appetite | 5 | 2023 | 69 | 0.490 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 547 | 0.490 |
Why?
| | Social Marketing | 2 | 2007 | 16 | 0.490 |
Why?
| | Autism Spectrum Disorder | 4 | 2025 | 395 | 0.490 |
Why?
| | Nutrition Assessment | 5 | 2021 | 92 | 0.490 |
Why?
| | Pleasure | 2 | 2014 | 19 | 0.460 |
Why?
| | Research Design | 5 | 2018 | 1139 | 0.460 |
Why?
| | Photography | 6 | 2021 | 96 | 0.460 |
Why?
| | Communication | 4 | 2020 | 879 | 0.450 |
Why?
| | Dietary Fats | 8 | 2020 | 304 | 0.440 |
Why?
| | Longitudinal Studies | 9 | 2020 | 2844 | 0.440 |
Why?
| | Dietary Carbohydrates | 4 | 2010 | 155 | 0.440 |
Why?
| | Cues | 3 | 2013 | 314 | 0.440 |
Why?
| | Paternal Behavior | 1 | 2014 | 5 | 0.440 |
Why?
| | Diet Records | 6 | 2025 | 83 | 0.430 |
Why?
| | Consumer Behavior | 4 | 2021 | 71 | 0.430 |
Why?
| | Psychometrics | 4 | 2019 | 720 | 0.420 |
Why?
| | Self Report | 6 | 2019 | 827 | 0.400 |
Why?
| | Reproducibility of Results | 10 | 2022 | 3284 | 0.400 |
Why?
| | Family Health | 1 | 2014 | 196 | 0.400 |
Why?
| | Visual Perception | 2 | 2011 | 160 | 0.380 |
Why?
| | Dietary Proteins | 3 | 2010 | 135 | 0.380 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 286 | 0.380 |
Why?
| | Failure to Thrive | 2 | 2009 | 29 | 0.360 |
Why?
| | Restaurants | 2 | 2021 | 25 | 0.360 |
Why?
| | Interviews as Topic | 5 | 2025 | 786 | 0.350 |
Why?
| | United States | 17 | 2024 | 14841 | 0.350 |
Why?
| | Professional-Family Relations | 2 | 2011 | 143 | 0.350 |
Why?
| | Size Perception | 1 | 2010 | 5 | 0.350 |
Why?
| | Educational Status | 3 | 2023 | 470 | 0.350 |
Why?
| | Child Development Disorders, Pervasive | 3 | 2018 | 62 | 0.350 |
Why?
| | Mental Recall | 4 | 2021 | 202 | 0.340 |
Why?
| | Lunch | 3 | 2020 | 7 | 0.330 |
Why?
| | Satiation | 5 | 2023 | 24 | 0.330 |
Why?
| | Medicine, Traditional | 1 | 2009 | 24 | 0.320 |
Why?
| | Focus Groups | 5 | 2019 | 522 | 0.320 |
Why?
| | Motor Activity | 5 | 2015 | 718 | 0.320 |
Why?
| | Child Health | 3 | 2022 | 154 | 0.320 |
Why?
| | Texas | 4 | 2020 | 244 | 0.310 |
Why?
| | Dietary Sugars | 2 | 2020 | 16 | 0.310 |
Why?
| | Sleep | 1 | 2016 | 755 | 0.310 |
Why?
| | Motor Skills | 2 | 2021 | 97 | 0.290 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2014 | 2531 | 0.290 |
Why?
| | Hyperglycemia | 2 | 2014 | 347 | 0.280 |
Why?
| | Social Control, Informal | 2 | 2013 | 21 | 0.280 |
Why?
| | Program Evaluation | 6 | 2021 | 898 | 0.270 |
Why?
| | Mass Screening | 2 | 2006 | 1287 | 0.270 |
Why?
| | Cell Phone | 2 | 2018 | 76 | 0.260 |
Why?
| | Middle Aged | 21 | 2025 | 33479 | 0.260 |
Why?
| | Motivation | 1 | 2011 | 570 | 0.260 |
Why?
| | Insulin Infusion Systems | 1 | 2010 | 394 | 0.250 |
Why?
| | Cultural Characteristics | 3 | 2018 | 67 | 0.250 |
Why?
| | Food, Fortified | 3 | 2022 | 42 | 0.240 |
Why?
| | Hypoglycemia | 1 | 2010 | 445 | 0.240 |
Why?
| | Principal Component Analysis | 2 | 2018 | 195 | 0.240 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 318 | 0.240 |
Why?
| | Micronutrients | 2 | 2025 | 92 | 0.240 |
Why?
| | Appetite Regulation | 3 | 2023 | 31 | 0.230 |
Why?
| | Weight Gain | 6 | 2020 | 519 | 0.220 |
Why?
| | Washington | 3 | 2020 | 156 | 0.220 |
Why?
| | Autistic Disorder | 2 | 2022 | 204 | 0.220 |
Why?
| | Program Development | 2 | 2017 | 364 | 0.220 |
Why?
| | India | 3 | 2020 | 195 | 0.210 |
Why?
| | Young Adult | 14 | 2020 | 13209 | 0.210 |
Why?
| | Insulin | 2 | 2014 | 2409 | 0.210 |
Why?
| | Adolescent | 16 | 2021 | 21513 | 0.200 |
Why?
| | Pilot Projects | 2 | 2025 | 1710 | 0.200 |
Why?
| | Food Quality | 2 | 2021 | 10 | 0.200 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2014 | 135 | 0.200 |
Why?
| | Diabetic Nephropathies | 1 | 2006 | 294 | 0.200 |
Why?
| | Snacks | 2 | 2020 | 19 | 0.190 |
Why?
| | Self Efficacy | 3 | 2020 | 396 | 0.190 |
Why?
| | Vocabulary | 1 | 2022 | 38 | 0.190 |
Why?
| | Economics, Behavioral | 1 | 2021 | 9 | 0.180 |
Why?
| | Teaching | 1 | 2003 | 224 | 0.180 |
Why?
| | Choice Behavior | 3 | 2021 | 170 | 0.180 |
Why?
| | Mindfulness | 1 | 2023 | 117 | 0.180 |
Why?
| | Perception | 4 | 2021 | 359 | 0.180 |
Why?
| | Nutrition Therapy | 1 | 2021 | 37 | 0.180 |
Why?
| | Infant Nutrition Disorders | 1 | 2020 | 11 | 0.170 |
Why?
| | Infant, Newborn | 8 | 2022 | 6079 | 0.170 |
Why?
| | Energy Metabolism | 7 | 2013 | 922 | 0.170 |
Why?
| | Beverages | 3 | 2015 | 69 | 0.170 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2111 | 0.160 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 10 | 0.160 |
Why?
| | Acculturation | 1 | 2020 | 53 | 0.160 |
Why?
| | Teacher Training | 1 | 2019 | 6 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2025 | 3556 | 0.150 |
Why?
| | Language | 1 | 2022 | 292 | 0.150 |
Why?
| | Social Support | 1 | 2023 | 618 | 0.150 |
Why?
| | Patient Compliance | 3 | 2017 | 581 | 0.150 |
Why?
| | Child Nutrition Sciences | 2 | 2012 | 8 | 0.150 |
Why?
| | Body Composition | 4 | 2010 | 684 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 660 | 0.150 |
Why?
| | Premature Birth | 1 | 2022 | 333 | 0.150 |
Why?
| | DNA Methylation | 1 | 2023 | 643 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 33 | 0.140 |
Why?
| | Weaning | 2 | 2012 | 47 | 0.140 |
Why?
| | Sodium, Dietary | 1 | 2018 | 41 | 0.140 |
Why?
| | Dietary Sucrose | 2 | 2015 | 49 | 0.140 |
Why?
| | Housing | 1 | 2019 | 146 | 0.140 |
Why?
| | Evidence-Based Practice | 4 | 2022 | 229 | 0.140 |
Why?
| | Cohort Studies | 5 | 2017 | 5742 | 0.140 |
Why?
| | Goals | 1 | 2018 | 170 | 0.130 |
Why?
| | Employment | 1 | 2018 | 178 | 0.130 |
Why?
| | Lipids | 1 | 2021 | 672 | 0.130 |
Why?
| | Reward | 1 | 2019 | 244 | 0.130 |
Why?
| | Telemedicine | 1 | 2025 | 862 | 0.120 |
Why?
| | Health Personnel | 1 | 2022 | 710 | 0.120 |
Why?
| | Adolescent Behavior | 1 | 2021 | 530 | 0.120 |
Why?
| | Minority Health | 1 | 2016 | 20 | 0.120 |
Why?
| | Age Factors | 4 | 2013 | 3295 | 0.120 |
Why?
| | Health Status Disparities | 1 | 2018 | 289 | 0.120 |
Why?
| | Self-Control | 1 | 2016 | 54 | 0.120 |
Why?
| | Candy | 1 | 2015 | 5 | 0.120 |
Why?
| | Diet, Fat-Restricted | 2 | 2008 | 79 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2016 | 1477 | 0.120 |
Why?
| | Hypoglycemic Agents | 2 | 2014 | 1291 | 0.110 |
Why?
| | Population Surveillance | 1 | 2018 | 482 | 0.110 |
Why?
| | Anthropometry | 3 | 2021 | 213 | 0.110 |
Why?
| | Quality Improvement | 1 | 2023 | 1178 | 0.110 |
Why?
| | Linear Models | 2 | 2015 | 849 | 0.110 |
Why?
| | Health | 1 | 2015 | 84 | 0.110 |
Why?
| | Insulin Lispro | 1 | 2014 | 39 | 0.110 |
Why?
| | Sulfonylurea Compounds | 1 | 2014 | 48 | 0.110 |
Why?
| | Insulin, Long-Acting | 1 | 2014 | 63 | 0.110 |
Why?
| | Executive Function | 1 | 2019 | 451 | 0.110 |
Why?
| | Income | 1 | 2015 | 202 | 0.110 |
Why?
| | Urban Health | 1 | 2014 | 92 | 0.110 |
Why?
| | Life Style | 2 | 2014 | 490 | 0.100 |
Why?
| | Pyrazines | 1 | 2014 | 90 | 0.100 |
Why?
| | Reference Values | 2 | 2015 | 816 | 0.100 |
Why?
| | Triazoles | 1 | 2014 | 147 | 0.100 |
Why?
| | Growth | 1 | 2012 | 60 | 0.100 |
Why?
| | Hypertriglyceridemia | 1 | 2012 | 39 | 0.100 |
Why?
| | Analysis of Variance | 3 | 2017 | 1316 | 0.090 |
Why?
| | Sex Factors | 4 | 2015 | 2071 | 0.090 |
Why?
| | Community Health Nursing | 1 | 2012 | 61 | 0.090 |
Why?
| | Sweetening Agents | 1 | 2012 | 54 | 0.090 |
Why?
| | Apolipoprotein C-III | 1 | 2011 | 12 | 0.090 |
Why?
| | Attitude | 2 | 2018 | 259 | 0.090 |
Why?
| | Eicosapentaenoic Acid | 1 | 2011 | 39 | 0.090 |
Why?
| | Heptanoic Acids | 1 | 2011 | 66 | 0.090 |
Why?
| | Follow-Up Studies | 4 | 2018 | 5131 | 0.090 |
Why?
| | Trace Elements | 1 | 2011 | 51 | 0.090 |
Why?
| | Docosahexaenoic Acids | 1 | 2011 | 84 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1153 | 0.090 |
Why?
| | Infusions, Subcutaneous | 1 | 2010 | 23 | 0.090 |
Why?
| | Diet Surveys | 3 | 2006 | 95 | 0.090 |
Why?
| | Feeding Methods | 1 | 2010 | 6 | 0.080 |
Why?
| | Emotions | 1 | 2016 | 548 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 605 | 0.080 |
Why?
| | Blood Glucose | 3 | 2014 | 2186 | 0.080 |
Why?
| | Injections, Subcutaneous | 1 | 2010 | 157 | 0.080 |
Why?
| | Pyrroles | 1 | 2011 | 213 | 0.080 |
Why?
| | Vitamins | 1 | 2011 | 185 | 0.080 |
Why?
| | Triglycerides | 1 | 2012 | 524 | 0.080 |
Why?
| | Postprandial Period | 1 | 2010 | 107 | 0.080 |
Why?
| | Monitoring, Ambulatory | 1 | 2010 | 87 | 0.080 |
Why?
| | Anthropology, Cultural | 1 | 2009 | 22 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2014 | 10811 | 0.080 |
Why?
| | Risk Assessment | 2 | 2009 | 3457 | 0.080 |
Why?
| | Mexico | 2 | 2020 | 225 | 0.080 |
Why?
| | Dyslipidemias | 1 | 2011 | 176 | 0.080 |
Why?
| | Health Care Costs | 1 | 2012 | 398 | 0.080 |
Why?
| | Aged | 8 | 2015 | 23961 | 0.070 |
Why?
| | Adiposity | 1 | 2013 | 518 | 0.070 |
Why?
| | Prevalence | 3 | 2018 | 2734 | 0.070 |
Why?
| | Attitude to Health | 1 | 2011 | 439 | 0.070 |
Why?
| | Safety | 1 | 2010 | 338 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2010 | 1946 | 0.070 |
Why?
| | Pregnancy | 4 | 2023 | 6763 | 0.070 |
Why?
| | Depression | 1 | 2016 | 1397 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2019 | 15657 | 0.070 |
Why?
| | Brain | 1 | 2019 | 2668 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 530 | 0.060 |
Why?
| | Time Factors | 3 | 2018 | 6828 | 0.060 |
Why?
| | Hyperphagia | 2 | 2019 | 34 | 0.060 |
Why?
| | Software | 1 | 2011 | 665 | 0.060 |
Why?
| | Drug Therapy, Combination | 3 | 2014 | 1066 | 0.060 |
Why?
| | Birth Weight | 1 | 2009 | 516 | 0.060 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2006 | 92 | 0.060 |
Why?
| | Socioeconomic Factors | 3 | 2017 | 1289 | 0.060 |
Why?
| | Albuminuria | 1 | 2006 | 185 | 0.060 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 201 | 0.060 |
Why?
| | Risk Factors | 4 | 2018 | 10388 | 0.060 |
Why?
| | False Negative Reactions | 1 | 2005 | 53 | 0.060 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2010 | 641 | 0.060 |
Why?
| | Counseling | 1 | 2008 | 391 | 0.060 |
Why?
| | False Positive Reactions | 1 | 2005 | 115 | 0.060 |
Why?
| | Cost-Benefit Analysis | 2 | 2005 | 591 | 0.060 |
Why?
| | Thinness | 1 | 2004 | 91 | 0.050 |
Why?
| | Observation | 2 | 2015 | 50 | 0.050 |
Why?
| | Social Class | 1 | 2006 | 282 | 0.050 |
Why?
| | Appetitive Behavior | 1 | 2023 | 9 | 0.050 |
Why?
| | Netherlands | 1 | 2023 | 88 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2005 | 366 | 0.050 |
Why?
| | Sucrose | 1 | 2003 | 110 | 0.050 |
Why?
| | Health Expenditures | 1 | 2005 | 189 | 0.050 |
Why?
| | CpG Islands | 1 | 2023 | 157 | 0.050 |
Why?
| | Satiety Response | 3 | 2008 | 10 | 0.050 |
Why?
| | Psychology, Child | 1 | 2002 | 38 | 0.050 |
Why?
| | Animals | 1 | 2024 | 36940 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2002 | 169 | 0.050 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 26 | 0.040 |
Why?
| | Menu Planning | 1 | 2021 | 5 | 0.040 |
Why?
| | Dairy Products | 2 | 2014 | 36 | 0.040 |
Why?
| | Fetal Blood | 1 | 2023 | 327 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1509 | 0.040 |
Why?
| | Environment | 1 | 2002 | 358 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2003 | 696 | 0.040 |
Why?
| | Food Ingredients | 1 | 2020 | 1 | 0.040 |
Why?
| | Metformin | 2 | 2014 | 331 | 0.040 |
Why?
| | Agriculture | 1 | 2021 | 103 | 0.040 |
Why?
| | Weight Loss | 4 | 2008 | 787 | 0.040 |
Why?
| | Factor Analysis, Statistical | 2 | 2011 | 283 | 0.040 |
Why?
| | Technology | 1 | 2020 | 96 | 0.040 |
Why?
| | History, 21st Century | 1 | 2020 | 213 | 0.040 |
Why?
| | Computers, Handheld | 1 | 2019 | 25 | 0.040 |
Why?
| | History, 20th Century | 1 | 2020 | 325 | 0.040 |
Why?
| | Family | 2 | 2019 | 671 | 0.040 |
Why?
| | Spinacia oleracea | 1 | 2018 | 9 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 1993 | 0.040 |
Why?
| | Incidence | 1 | 2005 | 2804 | 0.040 |
Why?
| | United States Department of Agriculture | 1 | 2017 | 4 | 0.030 |
Why?
| | Video Recording | 1 | 2018 | 180 | 0.030 |
Why?
| | Chicago | 1 | 2017 | 61 | 0.030 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2017 | 20 | 0.030 |
Why?
| | Serving Size | 1 | 2017 | 1 | 0.030 |
Why?
| | Culture | 1 | 2018 | 128 | 0.030 |
Why?
| | Wireless Technology | 1 | 2017 | 13 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7604 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1431 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 282 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2002 | 786 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2018 | 275 | 0.030 |
Why?
| | Research Personnel | 1 | 2017 | 173 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 956 | 0.030 |
Why?
| | European Union | 1 | 2014 | 12 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2018 | 2828 | 0.030 |
Why?
| | Sitagliptin Phosphate | 1 | 2014 | 33 | 0.030 |
Why?
| | Research Report | 1 | 2015 | 83 | 0.030 |
Why?
| | Receptors, Glucagon | 1 | 2014 | 27 | 0.030 |
Why?
| | Drug Substitution | 1 | 2014 | 54 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 820 | 0.030 |
Why?
| | Alabama | 1 | 2013 | 33 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2014 | 82 | 0.030 |
Why?
| | Insulin Glargine | 1 | 2014 | 84 | 0.030 |
Why?
| | Comorbidity | 1 | 2018 | 1622 | 0.030 |
Why?
| | Cross-Over Studies | 2 | 2008 | 564 | 0.030 |
Why?
| | Urban Population | 1 | 2016 | 479 | 0.030 |
Why?
| | Thiazolidinediones | 1 | 2014 | 137 | 0.030 |
Why?
| | Play and Playthings | 1 | 2013 | 33 | 0.030 |
Why?
| | Early Medical Intervention | 1 | 2013 | 57 | 0.030 |
Why?
| | Breakfast | 1 | 2013 | 20 | 0.030 |
Why?
| | Deficiency Diseases | 1 | 2012 | 10 | 0.020 |
Why?
| | Endocrine System | 1 | 2012 | 20 | 0.020 |
Why?
| | Food Analysis | 1 | 2012 | 26 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2014 | 786 | 0.020 |
Why?
| | Observer Variation | 1 | 2013 | 343 | 0.020 |
Why?
| | Self Concept | 1 | 2013 | 253 | 0.020 |
Why?
| | Administration, Oral | 1 | 2014 | 816 | 0.020 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 22 | 0.020 |
Why?
| | Pancreatitis | 1 | 2012 | 134 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2011 | 116 | 0.020 |
Why?
| | Education | 1 | 2011 | 108 | 0.020 |
Why?
| | Risk | 1 | 2013 | 912 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2012 | 227 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 499 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2013 | 261 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 692 | 0.020 |
Why?
| | Faculty | 1 | 2011 | 147 | 0.020 |
Why?
| | Public Assistance | 1 | 2010 | 20 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1101 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2011 | 365 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1266 | 0.020 |
Why?
| | Internet | 1 | 2013 | 655 | 0.020 |
Why?
| | Dietary Fiber | 1 | 2008 | 54 | 0.020 |
Why?
| | Kansas | 1 | 2008 | 32 | 0.020 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 445 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2057 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3566 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2012 | 1317 | 0.020 |
Why?
| | Health Surveys | 1 | 2008 | 514 | 0.020 |
Why?
| | Universities | 1 | 2008 | 433 | 0.010 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2003 | 23 | 0.010 |
Why?
| | Sample Size | 1 | 2003 | 125 | 0.010 |
Why?
| | Plethysmography, Impedance | 1 | 2002 | 5 | 0.010 |
Why?
| | Videotape Recording | 1 | 2002 | 35 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 7635 | 0.010 |
Why?
| | Abdomen | 1 | 2003 | 125 | 0.010 |
Why?
| | Nebraska | 1 | 2002 | 18 | 0.010 |
Why?
| | Deuterium Oxide | 1 | 2002 | 16 | 0.010 |
Why?
| | Reference Standards | 1 | 2002 | 186 | 0.010 |
Why?
| | Absorptiometry, Photon | 1 | 2002 | 259 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 1024 | 0.010 |
Why?
| | Inflammation | 1 | 2012 | 2837 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 553 | 0.010 |
Why?
| | Fatty Acids | 1 | 2003 | 443 | 0.010 |
Why?
| | Models, Statistical | 1 | 2003 | 669 | 0.010 |
Why?
| | Exercise Therapy | 1 | 2003 | 443 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2003 | 635 | 0.010 |
Why?
| | Phenotype | 1 | 2002 | 3196 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|